UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$881M |
| 3 |
Amazon
AMZN
|
+$613M |
| 4 |
Tesla
TSLA
|
+$540M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$502M |
Top Sells
| 1 |
Abbott
ABT
|
+$959M |
| 2 |
Linde
LIN
|
+$929M |
| 3 |
Exxon Mobil
XOM
|
+$336M |
| 4 |
VMW
VMware, Inc
VMW
|
+$225M |
| 5 |
NVIDIA
NVDA
|
+$199M |
Sector Composition
| 1 | Technology | 30.4% |
| 2 | Healthcare | 13.37% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 10.99% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Mr. Cooper
COOP
$14.1B
| $3.35M | ﹤0.01% |
62,490
-19,009
| -23% | -$1.02M |
|
1327
Korn Ferry
KFY
$3.79B
| $3.34M | ﹤0.01% |
70,455
-2,874
| -4% | -$136K |
|
1328
Carvana
CVNA
$50B
| $3.34M | ﹤0.01% |
79,486
-69,287
| -47% | -$2.91M |
|
1329
Chewy
CHWY
$14.4B
| $3.31M | ﹤0.01% |
181,504
+17,647
| +11% | +$322K |
|
1330
Ziff Davis
ZD
$1.5B
| $3.31M | ﹤0.01% |
51,930
-171
| -0.3% | -$10.9K |
|
1331
O-I Glass
OI
$1.99B
| $3.29M | ﹤0.01% |
196,827
-9,098
| -4% | -$152K |
|
1332
Corcept Therapeutics
CORT
$7.68B
| $3.29M | ﹤0.01% |
120,787
-12,564
| -9% | -$342K |
|
1333
Hillenbrand
HI
$1.73B
| $3.28M | ﹤0.01% |
77,491
-1,857
| -2% | -$78.6K |
|
1334
UMB Financial
UMBF
$9.16B
| $3.28M | ﹤0.01% |
52,821
+672
| +1% | +$41.7K |
|
1335
American Eagle Outfitters
AEO
$3.18B
| $3.26M | ﹤0.01% |
196,379
+6,147
| +3% | +$102K |
|
1336
Artisan Partners
APAM
$3.27B
| $3.26M | ﹤0.01% |
87,027
+8,482
| +11% | +$317K |
|
1337
QuantumScape
QS
$5.63B
| $3.22M | ﹤0.01% |
480,944
+67,300
| +16% | +$450K |
|
1338
ABM Industries
ABM
$2.8B
| $3.21M | ﹤0.01% |
80,121
-3,049
| -4% | -$122K |
|
|
EDR
1339
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $3.2M | ﹤0.01% |
160,983
+95,341
| +145% | +$1.9M |
|
1340
CNO Financial Group
CNO
$3.8B
| $3.2M | ﹤0.01% |
134,716
-20,614
| -13% | -$489K |
|
1341
iRhythm Technologies
IRTC
$5.78B
| $3.19M | ﹤0.01% |
33,861
+191
| +0.6% | +$18K |
|
1342
CVB Financial
CVBF
$2.77B
| $3.18M | ﹤0.01% |
192,171
+20,482
| +12% | +$339K |
|
1343
Immunovant
IMVT
$2.82B
| $3.18M | ﹤0.01% |
82,916
+31,194
| +60% | +$1.2M |
|
1344
Navient
NAVI
$1.28B
| $3.17M | ﹤0.01% |
184,260
-50,073
| -21% | -$862K |
|
1345
Ameris Bancorp
ABCB
$5.1B
| $3.17M | ﹤0.01% |
82,546
+8,456
| +11% | +$325K |
|
1346
Rapid7
RPD
$1.27B
| $3.16M | ﹤0.01% |
68,995
+3,560
| +5% | +$163K |
|
1347
Kadant
KAI
$3.69B
| $3.16M | ﹤0.01% |
14,003
+1,114
| +9% | +$251K |
|
1348
Select Medical
SEM
$1.55B
| $3.16M | ﹤0.01% |
231,944
+17,843
| +8% | +$243K |
|
1349
Kulicke & Soffa
KLIC
$2.01B
| $3.16M | ﹤0.01% |
64,913
-10,663
| -14% | -$519K |
|
1350
Arvinas
ARVN
$568M
| $3.16M | ﹤0.01% |
160,706
-868
| -0.5% | -$17K |
|